When a client does not respond to other antipsychotics, which medication is commonly initiated for treatment-resistant schizophrenia?

When a client does not respond to other antipsychotics, which medication is commonly initiated for treatment-resistant schizophrenia?

• A. Haloperidol decanoate
• B. Fluphenazine decanoate
• C. Perfenazine
• D. Clozapine (Clozaril)

Answer: (D)

When symptoms of schizophrenia don’t respond to standard antipsychotics, the medication most supported by evidence is clozapine, because it has unique efficacy in treatment-resistant cases. It’s the only antipsychotic with strong data showing meaningful improvement after trials of other agents at adequate doses and durations. This makes it the preferred option when patients fail to respond to typical antipsychotics.

Clozapine’s benefits in treatment resistance go beyond symptom reduction; it also lowers the risk of suicidality in schizophrenia, which is particularly important for patients at high risk. However, its use comes with significant safety considerations. The most notable risk is agranulocytosis, a dangerous drop in white blood cells, which is why clozapine requires regular blood monitoring. The monitoring starts with frequent checks and becomes less frequent over time, but it remains a lifelong requirement. Other potential side effects include weight gain, metabolic changes, seizures, myocarditis, and sedation, so ongoing assessment is essential.

The other options are long-acting injectable antipsychotics or a typical antipsychotic that don’t specifically address treatment resistance. Long-acting injectables can help with adherence and maintenance but are not chosen specifically for overcoming nonresponse to other antipsychotics. A typical antipsychotic may control symptoms for some, but they generally have a higher risk of extrapyramidal symptoms and have not demonstrated superior efficacy in treatment-resistant schizophrenia compared with clozapine.

So, in a client with schizophrenia who does not respond to other antipsychotics, initiating clozapine is the best-supported choice due to its unique effectiveness in TRS, balanced with the necessary safety monitoring to manage its risks.